ResMed is a leading developer, manufacturer and marketer of products for the screening, treatment and long-term management of sleep-dsordered breathing (SDB) and other respiratory orders. The  Australian company was founded in 1989 with a primary ourpose of commercializing a device for treating obstructive sleep apnea (OSA), the most common form of SDB. The company is dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing.
Through clinical research studies, company is  able to improve current treatment, discover new areas of treatment and enhance product development to better serve our patients. Company works with respected medical centers and clinical research professionals around the country.
For information on a particular study please see the various study links: Glycosa Study | CompSAS Resolution Study | Opiod Study

The company has ISO 9001, ISO 13485, CE 0120 manufacturing facility and product quality certification. 

The company is ASX (Australian Stock Exchange) and NYSE (New York Stock Exchange) listed and operates in more then 70 countries through Direct Operations and a network of Distributors.

To read more about ResMed Worldclass Productline, visit: . For ResMed YouTube Channel: Click Here